97180 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
Cell display of antibody libraries
#302Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin
#303Method for the treatment of fibrosis
#304Administration of agents for the treatment of inflammation
#305Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
#306Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
#307Method for treating or preventing steroid-induced glaucoma
#308Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
#309Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics
#310Method for inhibiting "melanoma inhibitory activity" mia
#311Monoclonal antibody capable of binding integrin alpha 10 beta 1
#312Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
#313Humanized anti-VLA4 immunoglobulins
#314Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
#315Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins
#316Alpha 5 beta 1 and its ability to regulate the cell survival pathway
#317Treatment of viral encephalitis by agents blocking alpha-VLA-4 integrin function
#318Treatment for asthma
#319Steroid sparing agents and methods of using same
#320Recombinant anti-osteopontin antibody and use thereof
#321Method for the treatment of fibrosis
#322Use of anti-α5β1 antibodies to inhibit cancer cell proliferation
#323Cytomegalovirus disintegrin-like peptides
#324Steroid sparing agents and methods of using same
#325Methods and composition for treating tumors and metastatic disease
#326Methods of implating mesenchymal stem cells for tissue repair and formation
#327Method for the treatment of inflammatory disorders
#328Medical devices and methods for modulating cell adhesion
#329Detection of secreted polypeptides
#330Treatment for insulin dependent diabetes
#331Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
#332Methods for inhibiting angiogenesis
#333Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
#334Methods of production and use of anti-integrin antibodies for the control of tissue granulation